In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions
ConditionFetal Alcohol Syndrome
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversity Hospital, Rouen
About this trial
This study aims to validate that PLGF is a biomarker of cerebral lesions and therefore of secondary developmental disorders and disabilities that will be best diagnosed at 2 and 6 years of age.
Eligibility criteria
Qualifiers
Pregnant woman (monofetal or twin pregnancy, whatever the parity)
Age> or = to 18 years
Person affiliated to a social security system
Person who read and understood the information form and signed the consent form
Disqualifiers
Female under 18
Pregnant woman with clinical suspicion of pre-eclampsia and / or HELLP syndrome
Person deprived of liberty by an administrative or judicial decision or protected major subject (under tutorship or curatorship)
Patient participating in another interventional trial or who participated in another interventional trial during pregnancy
Trial design
Treatments tested in this trial
- ASQ parental questionnaire
- Development scales
- Scale of Conners
- SCQ Questionnaire
- Blood sample (mother)
- Cord blood sample
- Placenta sample
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov